Evaluation of long-term management of pediatric bronchial asthma – Effects of bronchodilators in combination of antileukotrienes –

Not Applicable

• Conditions: asthma

• Registration Number: JPRN-UMIN000002921
• Lead Sponsor: PARG (Pediatric Asthma Research Group)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-12-28
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 140

Inclusion Criteria

Not provided

Exclusion Criteria

 Children who are receiving long-acting beta2 agonists (tulobuterol patch or inhaled salmeterol) or oral beta2 agonists regularly.  Children with a history of hypersensitivity to tulobuterol patch, and children with dermal diseases such as atopic dermatitis for whom treatment with tulobuterol patch are considered inappropriate.  Children with hyperthyroidism, hypertension, heart disease or diabetes mellitus for whom treatment with beta2 agonists is considered inappropriate.  Children with a history of serious adverse effects of tulobuterol. Children with a history of serious adverse effects of theophylline.  Children with epilepsy, hyperthyroidism, acute nephritis, congestive heart failure or liver disorder for whom treatment with theophylline is considered inappropriate.  Children with neurological dispositions (e.g., epilepsy, convulsions and abnormal EEG)  Children with fever  Any other children for whom participation in the survey is considered inappropriate by the attending physicians.

Study & Design

• Study Type: Interventional
• Study Design: Not specified